| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 387.263 | 2.813 | 156 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 389.777 | 7.795 | 178 | 3.611 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 389.752 | 41.593 | 9.866 | 405 | 156 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 25 | -33.799 | -9.687 | 3.206 | -156 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 21 | -33.799 | -12.035 | 3.206 | -156 | 0 | 0 | 0 | 0 | - |
| Employees | 9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Cirofetim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.569 | 15.415 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 44.767 | 2.537 | 1.496 | 770 | 599 | 588 | 575 | 576 | 575 | - |
| Inventories | 12.883 | 720 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 1.323 | 1.160 | 1.474 | 764 | 599 | 588 | 575 | 576 | 575 | - |
| Cash | 30.560 | 657 | 23 | 7 | 0 | 0 | 0 | 0 | 0 | - |
| Shareholders Funds | 4.548 | -44.958 | -56.232 | -51.945 | -51.095 | -50.127 | -49.015 | -49.167 | -49.018 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 64.895 | 63.067 | 57.728 | 52.715 | 51.694 | 50.714 | 49.590 | 49.743 | 49.593 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Cirofetim Srl